LIAISON PLEXÂ Gram-Positive Blood Culture Assay Gets 510(k) Nod
Diasorin has received FDA 510(k) clearance for its LIAISON PLEX Gram-Positive Blood Culture Assay, completing its syndromic blood culture portfolio.
Diasorin has received FDA 510(k) clearance for its LIAISON PLEX Gram-Positive Blood Culture Assay, completing its syndromic blood culture portfolio.
The Aries SARS-CoV-2 assay will run on the company's Aries system, an FDA-cleared, automated molecular diagnostics platform for moderate-complexity labs.
The newly signed agreement expands the partners’ current arrangements, adding global distribution of Luminex multiplexing instrumentation through 2020.